Progression of Cardiovascular Autonomic Dysfunction in Patients With Type 2 Diabetes
Open Access
- 1 September 2008
- journal article
- Published by American Diabetes Association in Diabetes Care
- Vol. 31 (9) , 1832-1836
Abstract
OBJECTIVE—We investigated whether cardiovascular autonomic dysfunction was associated with glycemic control status over time in patients with type 2 diabetes. RESEARCH DESIGN AND METHODS—From 1999 to 2000, cardiovascular autonomic nerve function testing (AFT) was performed on patients with type 2 diabetes (n = 1,021) and was followed-up in 2006 and February 2008. Tests for cardiovascular autonomic functions measured heart rate variability parameters (expiration-to-inspiration [E/I] ratio, responses to the Valsalva maneuver, and standing). AFT scores were determined from the results of the each test as follows: 0 for normal and 1 for abnormal. We began with those who had a score of 0 and assessed the changes in total score along with biannual A1C levels. RESULTS—At follow-up, the development of cardiovascular autonomic dysfunction was 34.5% (E/I ratio 21.9%, Valsalva maneuver 77.8%, and posture 58.9%; n = 783). The development of cardiovascular autonomic dysfunction was higher in older patients (P < 0.001); in those with longer duration of diabetes (P < 0.001); of hypertension (P = 0.005), and of diabetic retinopathy (P < 0.001); and in those who had higher levels of microalbuminuria (P = 0.002). Logistic regression analysis revealed that the development of cardiovascular autonomic dysfunction was strongly associated with the mean A1C level during the follow-up period (mean A1C >9.0% vs. ≤7.0%, odds ratio 2.984, 95% CI 1.177–7.561; P = 0.021). CONCLUSIONS—The development of cardiovascular autonomic dysfunction was independently associated with microvascular complications and glycemic control status during this 7.5-year follow-up in patients with type 2 diabetes.Keywords
This publication has 26 references indexed in Scilit:
- Prevention of Cardiovascular Disease in Persons with Type 2 Diabetes Mellitus: Current Knowledge and Rationale for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) TrialThe American Journal of Cardiology, 2007
- Diabetic Cardiovascular Autonomic NeuropathyCirculation, 2007
- Vascular Risk Factors and Diabetic NeuropathyNew England Journal of Medicine, 2005
- Diabetic Autonomic NeuropathyDiabetes Care, 2003
- Neuropathy profile of diabetic patients in a pancreas transplantation programNeurology, 1995
- Assessment of Cardiovascular Autonomic Function: Age‐related Normal Ranges and Reproducibility of Spectral Analysis, Vector Analysis, and Standard Tests of Heart Rate Variation and Blood Pressure ResponsesDiabetic Medicine, 1992
- The epidemiology of diabetic neuropathyJournal of Diabetes and its Complications, 1992
- Simple immunoturbidimetric method for determining urinary albumin at low concentrations using Cobas-Bio centrifugal analyser.Journal of Clinical Pathology, 1987
- The Value of Cardiovascular Autonomic Function Tests: 10 Years Experience in DiabetesDiabetes Care, 1985
- Nerve function and metabolic control in teenage diabeticsDiabetes, 1983